Donald Robert Schemel serves as Executive at Sun BioPharma, Inc., where they oversee executive responsibilities. Since joining the company, Donald Robert Schemel has executed 4 insider transactions totaling $10.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 4, 2022 involved purchasing 200,000 shares valued at $0.
Donald Robert Schemel currently holds 482,654 shares of Sun BioPharma, Inc. (SNBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald Robert Schemel has been a net seller of SNBP stock. They have purchased $0 and sold $10.0K worth of shares.
Donald Robert Schemel's most recent insider trade was on Oct 4, 2022, when they purchased 200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 1, 2020 | PBLA | $0 | Award | 2,875 | $N/A | Discretionary |
| Nov 14, 2016 | SNBP | $10.0K | Sale | 7,000 | $1.43 | Discretionary |